Beilu Pharmaceutical has been awarded "Beijing Advanced Unit of Adverse Drug Reactions Daily Monitoring" for 4 consecutive years.

Recently, the Beijing Municipal Drug Administration and Beijing Municipal Health Commission issued the "notice on the outstanding Performance of units and individuals in the monitoring of adverse Reactions of pharmaceutical, devices and cosmetics in 2021". In this Notice, Beijing Beilu Pharmaceutical Co., Ltd. won the title of " Beijing Advanced Unit of Adverse Drug Reactions Daily Monitoring ". Zhou Chenchen of Pharmacovigilance Department was awarded the title of "Beijing Excellent Individual for Adverse Drug Reaction Monitoring Work".

Beilu Pharmaceutical has been awarded the honorary title of " Advanced Unit of Adverse Drug Reactions Daily Monitoring " for 4 Consecutive years. We hereby express our thanks and congratulations to all the staff of Pharmacovigilance Department. We are willing to make unremitting efforts in our work and achieve greater achievements in the future.